黑龙江医药2024,Vol.37Issue(4) :809-812.DOI:10.14035/j.cnki.hljyy.2024.04.020

低强度红光眼部照射对青少年近视防控效果的临床研究

Clinical Study on the Prevention and Control Effect of Low Intensity Red Light Eye Irradiation on Juvenile Myopia

许慕岚 张霞宇 李恩钦
黑龙江医药2024,Vol.37Issue(4) :809-812.DOI:10.14035/j.cnki.hljyy.2024.04.020

低强度红光眼部照射对青少年近视防控效果的临床研究

Clinical Study on the Prevention and Control Effect of Low Intensity Red Light Eye Irradiation on Juvenile Myopia

许慕岚 1张霞宇 1李恩钦1
扫码查看

作者信息

  • 1. 赣州启明星眼科医院(江西 赣州 341000)
  • 折叠

摘要

目的:分析低强度红光眼部照射对青少年近视防控的效果.方法:选取2021年8月—2023年8月赣州启明星眼科医院门诊接诊的86例近视患者,按随机数字表法分为两组,各43例.对照组行基础近视配镜治疗,观察组行低强度红光眼部照射治疗.对比两组临床疗效、眼轴长度、最佳矫正视力(BCVA).结果:观察组治疗总有效率为95.35%(41/43),高于对照组的81.40%(35/43);且治疗后的眼轴长度为(24.50±1.21)mm,短于对照组的(25.43±1.46)mm,BCVA为(0.62±0.13),高于对照组的(0.49±0.07),P<0.05.结论:低强度红光眼部照射可有效提高青少年近视患者视力,控制眼轴增长.

Abstract

Objective:To analyze the effect of low-intensity red light eye irradiation on the prevention and control of myopia in ad-olescents.Methods:A total of 86 patients with myopia admitted to the outpatient department of Ganzhou QIMINGXING eye hospital from August 2021 to August 2023 were randomly divided into two groups,43 cases in each group.The control group was treated with basic myopia with glasses,and the observation group was treated with low-intensity red light eye irradiation.The clinical efficacy,axial length and best corrected visual acuity(BCVA)of the two groups were compared.Results:The total effective rate of the observation group was 95.35%(41g43),which was higher than 81.40%(35/43)of the control group;After treatment,the axial length was(24.50±1.21)mm,shorter than(25.43±1.46)mm in the control group,and the BCVA was(0.62±0.13),higher than(0.49±0.07)in the control group(P<0.05).Conclusion:Low intensity red light eye irradiation can effectively improve the visual acuity of juvenile myopia patients and control the growth of ocular axis.

关键词

近视/低强度红光/眼轴/最佳矫正视力/眼轴

Key words

Myopia/Low intensity red light/Ocular axis/Best corrected visual acuity/Ocular axis

引用本文复制引用

基金项目

赣州市指导性科技计划项目(20222ZDX7573)

出版年

2024
黑龙江医药
黑龙江省药品审评认证中心

黑龙江医药

影响因子:0.597
ISSN:1006-2882
参考文献量10
段落导航相关论文